2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Print

Poster Session

[P42] Poster Session 42　Gastrointestinal Cancer（Esophageal Cancer 2）

[P42-1] Correlation of PD-L1 expression and clinical efficacy for advanced ESCC treated with nivolumab monotherapy

○Hayato Mikuni1,2, Shun Yamamoto1, Ryoichi Sawada2, Yoshitaka Honma1, Shigeki Sekine3, Koshiro Ishiyama4, Junya Oguma4, Masayuki Saruta2, Hiroyuki Daiko4, Ken Kato1 (1.Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 2.Department of Gastroenterology and Hepatology, Jikei University Hospital, 3.Department of Diagnostic Pathology, National Cancer Center Hospital, 4.Department of Esophageal Surgery, National Cancer Center Hospital)

[P42-2] Real World Data on Immune Checkpoint Inhibitors as Later Line Treatment for Esophageal Cance

○Shunsuke Ueyama1, Yamada Takeshi2, Sugaya Akinori3, Hamano Yukako4, Tsui Miki2, Hirose Suguru2, Niisato Yusuke2, Kobayashi Mariko2, Yamamoto Yoshiyuki2, Moriwaki Toshikazu2, Tsuchiya Kiichiro2 (1.Division of Gastroenterology, Tsuchiura Kyodo General Hosipital, 2.Division of Gastroenterology, University of Tsukuba Hospital, 3.Division of Gastroenterology, Ibaraki Prefectural Central Hospita, 4.Division of Gastroenterology, Hitachi General Hospital)

[P42-3] Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer

○Osamu Maeda1, Satoshi Furune1, Mitsuro Kanda2, Kazushi Miyata3, Dai Shimizu2, Masahiko Koike2, Yasuhiro Kodera2, Yuichi Ando1 (1.Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 2.Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, 3.Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine)

[P42-4] Clinical experiences of combination therapy with cisplatin for the older-aged esophageal cancer patients

○Masahiro Hatori1, Nakayama Izuma2, Nakamura Masashi1, Kobayashi Kazuo1, Akira Ooki2, Ogura Mariko2, Osumi Hiroki2, Keitaro Shimozaki2, Wakatsuki Takeru2, Shinozaki Eiji2, Takahari Daisuke2, Chin Keisho2, Yamaguchi Kensei2, Yamaguchi Masakazu1 (1.Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 2.Department of Gastroenterological Chemotherapy, Cancer Institute Hospital, Japanese Foundation for Cancer Research,)

[P42-5] Optimal primary prophylaxis for febrile neutropenia during docetaxel, cisplatin, and 5-FU therapy for esophageal cancer

○Ryosuke Kumanishi1, Hiroya Taniguchi1, Kyoko Kato2, Taiko Nakazawa1, Takatsugu Ogata1, Yuki Matsubara1, Hiroyuki Kodama1, Akinobu Nakata1, Kazunori Honda1, Toshiki Masuishi1, Yukiya Narita1, Shigenori Kadowaki1, Masashi Ando1, Keiji Sugiyama2, Keisaku Yamada3, Sachiyo Ohnishi3, Tsutomu Tanaka3, Masahiro Tajika3, Tetsuya Abe4, Kei Muro1 (1.Department of Clinical Oncology, Aichi Cancer Center Hospital, 2.Department of Medical Oncology, National Hospital Organization Nagoya Medical Center., 3.Department of Endoscopy, Aichi Cancer Center Hospital, 4.Department of Gastroenterological Surgery, Aichi Cancer Center Hospital)

[P42-7] FOLFOX-based chemoradiotherapy for locally advanced/metastatic esophageal squamous cell carcinoma with severe dysphagia

○Kazuhiro Shiraishi1, Keiji Sugiyama1, Mariko Sato1, Riko Nishibori1, Kyoko Kato1, Hiroaki Uda2, Akifumi Miyakawa3, Ayuko Oguri3, Masaya Suenaga2, Masaaki Shimada4, Masato Kataoka2, Eriko Kato3, Chiyoe Kitagwa1 (1.Department of Medical Oncology, National Hospital Organization Nagoya Medical Center, 2.Department of Surgery, National Hospital Organization Nagoya Medical Center, 3.Department of Radiation Therapy, National Hospital Organization Nagoya Medical Center,, 4.Department of Gastroenterology, National Hospital Organization Nagoya Medical Center)